Neurocrine Clinical Site — Anaheim, California

Neurocrine Clinical Site is a clinical research site located in Anaheim, California, United States 92805.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

Neurocrine Clinical Site has participated in 13 clinical trials with 1 currently active.

Therapeutic areas: Tourette Syndrome, Tardive Dyskinesia, Tardive Dyskinesia (TD).

Sponsors: Neurocrine Biosciences.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Neurocrine Clinical Site?

Neurocrine Clinical Site has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Neurocrine Clinical Site conducted?

Neurocrine Clinical Site has 13 clinical trials on record, with 1 currently active. Their work covers Tourette Syndrome, Tardive Dyskinesia, Tardive Dyskinesia (TD).

Is Neurocrine Clinical Site accredited by Crixeo Health?

Neurocrine Clinical Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Neurocrine Clinical Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.